$14.910
+1.806 (+12.11%)收盘时
价格预测
在 App 中打开以解锁更长周期的预测。
该买入 ADARx Pharmaceuticals, Inc. 股票吗？
ADARx Pharmaceuticals is not a good buy right now due to its significant losses and declining stock performance. The current price is $13.15, which is 43.4% below its 52-week high of $23.21. Additionally, the company reported a net income loss of $25,759,000 in Q2 2026, indicating ongoing financial struggles. The main risk is its high price-to-sales ratio of 240.20, suggesting overvaluation relative to its revenue.
ADRX 股价于 Thursday 收于 $14.91，此前上涨 +12.11%
ADARx Pharmaceuticals, Inc. (ADRX) last closed at $14.9099998, gaining +12.11%. These facts feed the 1-day and 1-week ADRX price prediction above.
预测驱动因素
ADARx Pharmaceuticals, Inc.（ADRX）的预测驱动因素综合了相似的图表形态、季节性与移动平均线。
Seasonality
Bearish
SMA 20
Bearish
SMA 200
Bearish
ADRX 季节性分析
相关文章
- International Stocks vs US Stocks in 2026: How the Strong Dollar and Valuations Change the CaseInternational stocks vs US stocks in 2026: how the strong dollar, valuation gaps, Fed hikes and concentration risk shape a smarter global allocation plan now.
- Defensive Stocks in 2026: Is the Rush Into Staples and Healthcare Already Overcrowded?Investors are piling into defensive stocks as tech slides. See why staples and healthcare surged, why valuations look stretched, and how to avoid overpaying.
- Defense Stocks in 2026: How Midterms, the Iran War and a Stalled Budget Shape the OutlookDefense stocks fell after the 2026 midterms. Learn how the Iran war, the $1.5T budget request and the December 11 funding deadline shape the sector outlook.
本页仅供研究参考，不构成投资建议。模型可能出错。过往表现不代表未来结果。